title: What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?
authors.affiliation: Dr. Mark Lebwohl, MD, is Professor and Chairman, Department of Dermatology, The Mount Sinai School of Medicine, New York, NY.
authors.forename: Mark
authors.initials: M
authors.lastname: Lebwohl